Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.
      Google Scholar   
Citation:
J Clin Oncol vol 25 (13) 1698-704
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA77597, CA04457, CA11789, CA02599, CA47577, CA47555, CA32291, CA29165, CA41287, CA03927, U10 CA033601, CA26806, CA45389, CA45808, CA29511, CA12046, CA35421, CA86726, CA16450, CA77440, CA11028, CA45564, CA04326, CA08025, CA74811, CA21060, CA47559, CA47642, CA71323, CA77658, CA12449, CA37135, CA77298, CA07968  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-39801
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Area Under Curve, Carboplatin, Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant, Combined Modality Therapy, Female, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Survival Analysis